Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib

Wang S. X.; Zhang B.; Wakelee H. A.; Diehn M.; Kunder C.; Neal J. W.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib

【24h】

Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib

机译：案例系列遇到外显子14跳过突变阳性非小细胞肺癌并反应克里齐替尼

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2017年第1期|共1页
作者
Wang S. X.; Zhang B.; Wakelee H. A.; Diehn M.; Kunder C.; Neal J. W.;
展开▼
作者单位

Stanford Hosp &

Clin Palo Alto CA USA;

Stanford Hosp &

Clin Palo Alto CA USA;

Stanford Canc Inst Stanford CA USA;

Stanford Canc Inst Stanford CA USA;

Stanford Hosp &

Clin Palo Alto CA USA;

Stanford Canc Inst Stanford CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib [J] . Wang S. X., Zhang B., Wakelee H. A., International Journal of Radiation Oncology, Biology, Physics . 2017,第1期

机译：案例系列遇到外显子14跳过突变阳性非小细胞肺癌并反应克里齐替尼
2. Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib [J] . Wang Samantha X. Y., Zhang Bing M., Wakelee Heather A., Anti-cancer drugs . 2019,第5期

机译：案例系列遇到外显子14跳过突变阳性非小细胞肺癌，并反应Croizotinib和Cabozantibib
3. MET exon 14 skipping mutations in non-small cell lung cancer: efficient routine diagnostics, histopathology and clinical response upon targeted treatment [J] . Geurts-Giele W., Pruis M., von der Thusen J., Virchows Archiv: an international journal of pathology . 2019,第Suppla1期

机译：遇见外显子14在非小细胞肺癌中跳过突变：有效的常规诊断，组织病理学和靶向治疗后的临床反应
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Analysis of TWEAK Receptor (Fn14) Expression and Function in Non-small Cell Lung Cancer Cells. [D] . Cheng, Emily. 2014

机译：非小细胞肺癌细胞中TWEAK受体（Fn14）表达和功能的分析。
6. Lazarus-type response to crizotinib in a patient with poor performance status and advanced MET exon 14 skipping mutation-positive lung adenocarcinoma [O] . Meghan Shea, Mark S. Huberman, Daniel B. Costa -1

机译：表现状态差且MET外显子14跳过突变阳性肺腺癌的晚期患者对克唑替尼的Lazarus型反应
7. 398P Real-world mechanism of crizotinib-resistance in MET exon 14 skipping mutations non-small-cell lung cancer using next generation sequencing: A multicenter study [O] . D. Wang, W-X. Wang, C. Xu, 2020

机译：398P现实世界机制在遇到外显子抗性的抵抗力，使用下一代测序跳过突变非小细胞肺癌：多中心研究

Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib

著录项

相似文献

相关主题

期刊订阅